Land O’Lakes International Development and the International Livestock Research Institute (ILRI) are pleased to announce a webinar option for their meeting tomorrow, 4 May, in Nairobi, Kenya, on Animal Source Foods for Nutrition Impact: Evidence and Good Practices for Informed Project Design. This one-day event will be held on the ILRI Nairobi campus from 8:30am to 5:00pm on Thu 4 May 2017.
Thousands of Kenyans are being wrongly diagnosed and treated for the milk linked disease brucellosis, reveals a new study. Now researchers at the Kenya Medical Research Institute (Kemri) and six international institutions, want the responsible test withdrawn from public hospitals.
‘Forty eight out of 108 (44 per cent) cut pork meat samples collected at wet markets in Hưng Yên Province were found to contain the disease-causing bacteria Salmonella. . . .
‘The researchers determined that the probability of pork eaters in northern Hưng Yên Province becoming ill with salmonellosis from consuming infected pork in a given year is 18 per cent. . . .. However, this risk can be avoided,” Nguyễn Việt Hùng, representative for East and Southeast Asia and a senior scientist in eco-health and food safety at the International Livestock Research Institute (ILRI) told Việt Nam News.
‘Prof Eric Fèvre, a researcher of veterinary infectious diseases at the Institute of Infection and Global Health at the University of Liverpool and the International Livestock Research Institute (ILRI) in Nairobi told the Business Daily the close interaction between people and animals worsened the situation.
With hard work and persistence, growing animals for food can shift from being an important source of antimicrobial resistance to being an important part of the solution.
From the United States comes this good news about a new rule that has gone into effect curtailing use of antibiotics in livestock production with the aim of reducing the rise of antimicrobial resistance to drugs of medical importance.
Lethal bacteria are showing resistance to more and more antibiotics, and financial and legal hurdles are making it harder than ever for science to create effective new drugs. . . . The arsenal of antibiotics is nearly empty. And significant financial and legal hurdles are getting in the way of the already challenging process of discovering effective new ones.